Which portion of the sacroiliac joint should be accessed for steroid injection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Inferior Aspect of the Sacroiliac Joint

Access the inferior aspect of the sacroiliac joint for steroid injection, as this is the standard approach favored by most techniques and corresponds to the synovial portion of the joint. 1

Anatomical Rationale

The sacroiliac joint has distinct anatomical characteristics that dictate the optimal injection site:

  • The inferior third contains articular cartilage and synovium - this is the true synovial portion of the joint where corticosteroids can exert their anti-inflammatory effect 1
  • The superior two-thirds is primarily ligamentous with interosseous ligaments filling this space, making it unsuitable for intra-articular injection 2
  • The mid-portion and superior portions have been described as alternative access points, but these are technically challenging due to the lack of synovium 1

Technical Approach

When accessing the inferior aspect:

  • Target the junction of the middle and lower third of the joint, approximately 1.69 cm ± 0.63 cm above the lower edge 3
  • Use fluoroscopic guidance with the C-arm rotated to a contralateral oblique view of 5-20 degrees to superimpose the posterior and anterior joint lines 1
  • The needle should be positioned to reach the anterior third of the joint in lateral view for optimal intra-articular placement 4

Contrast Flow Pattern Considerations

While inferior access is standard, there is evidence suggesting that cephalad extension of the injectate may improve short-term outcomes:

  • Patients with cephalad contrast flow during injection showed improved pain scores at 2 weeks compared to those with poor cephalad extension 1
  • However, no significant differences existed at 8 weeks, with both groups improving significantly 1
  • This suggests the initial access point matters less than achieving adequate distribution within the joint

Important Caveats

No direct comparative studies exist evaluating superior versus inferior versus mid-portion access 1. The recommendation for inferior access is based on:

  • Anatomical considerations (presence of synovium)
  • Technical feasibility
  • Consensus among practitioners rather than outcome data

The estimated joint volume is approximately 1.4 mL (range 0.6-2.7 mL) 1. Injecting beyond this volume means the injectate reaches adjacent unintended structures, which may explain why injection accuracy doesn't always correlate with clinical outcomes.

Reasonable steroid dosing: 40 mg of methylprednisolone or triamcinolone (or pharmacologic equivalent) per sacroiliac joint 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.